Skip to content
naulon

No retraction, correction or concern found when last checked on Oct 31, 2026.

Fundus-controlled perimetry (microperimetry): Application as outcome measure in clinical trials

Maximilian Pfau, Jasleen Kaur Jolly, Zhichao Wu and 6 more

Progress in Retinal and Eye Research · 2021 · Review

doi:10.1016/j.preteyeres.2020.100907

Abstract

Fundus-controlled perimetry (FCP, also called 'microperimetry') allows for spatially-resolved mapping of visual sensitivity and measurement of fixation stability, both in clinical practice as well as research. The accurate spatial characterization of visual function enabled by FCP can provide insightful information about disease severity and progression not reflected by best-corrected visual acuity in a large range of disorders. This is especially important for monitoring of retinal diseases that initially spare the central retina in earlier disease stages. Improved intra- and inter-session retest-variability through fundus-tracking and precise point-wise follow-up examinations even in patients with unstable fixation represent key advantages of these technique. The design of disease-specific test patterns and protocols reduces the burden of extensive and time-consuming FCP testing, permitting a more meaningful and focused application. Recent developments also allow for photoreceptor-specific testing through implementation of dark-adapted chromatic and photopic testing. A detailed understanding of the variety of available devices and test settings is a key prerequisite for the design and optimization of FCP protocols in future natural history studies and clinical trials. Accordingly, this review describes the theoretical and technical background of FCP, its prior application in clinical and research settings, data that qualify the application of FCP as an outcome measure in clinical trials as well as ongoing and future developments.

Shown for reading. Its publisher allows quoting it, not republishing it.

References 295

  1. 1.

    Alexander P, Mushtaq F, Osmond C, Amoaku W, 2012. Microperimetric changes in neovascular age-related macular degeneration treated with ranibizumab. Eye 26, 678–683..

    Not in our library10.1038/eye.2012.7

  2. 2.

    Alonso-Plasencia M, Abreu-González R, Gómez-Culebras MA, 2019. Structure–function correlation using oct angiography and microperimetry in diabetic retinopathy. Clin. Ophthalmol 13, 2181–2188..

    Not in our library10.2147/opth.s220877

  3. 3.

    Altpeter EK, Blanke BR, Leo-Kottler B, Nguyen XN, Trauzettel-Klosinski S, 2013. Evaluation of fixation pattern and reading ability in patients with Leber hereditary optic neuropathy. J. neuro-ophthalmology Off. J. North Am. Neuro-Ophthalmology Soc 33, 344–348..

    Not in our library10.1097/wno.0b013e31829d1f5b

  4. 4.

    Amore FM, Fasciani R, Silvestri V, Crossland MD, de Waure C, Cruciani F, Reibaldi A, 2013. Relationship between fixation stability measured with MP-1 and reading performance. Ophthalmic Physiol. Optic 33, 611–617..

    Not in our library10.1111/opo.12048

  5. 5.

    Anderson RS, 2006. The psychophysics of glaucoma: improving the structure/function relationship. Prog. Retin. Eye Res 25, 79–97..

    Not in our library10.1016/j.preteyeres.2005.06.001

  6. 6.

    Artes PH, Iwase A, Ohno Y, Kitazawa Y, Chauhan BC, 2002. Properties of perimetric threshold estimates from full threshold, SITA standard, and SITA fast strategies. Invest. Ophthalmol. Vis. Sci 43, 2654–2659.

    Not in our library

  7. 7.

    Foerster R, Aubert H, 1857. Untersuchungen über den Raumsinn der Retina. Arch. für Opthalmologie 3, 1–37..

    Not in our library10.1007/bf02720715

  8. 8.

    Aulhorn E, Harms H, 2015. Early visual field defects in glaucoma, in: Glaucoma, pp. 151–186..

    Not in our library10.1159/000389404

  9. 9.

    Aulhorn E, Harms H, Raabe M, 1966. Die lichtunterschiedsempfindlichkeit als funktion der umfeldleuchtdichte. Doc. Ophthalmol 20, 537–556..

    Not in our library10.1007/bf00165440

  10. 10.

    Bach M, Schäfer K, 2016. Visual acuity testing: feedback affects neither outcome nor reproducibility, but leaves participants happier. PloS One 11. e0147803–e0147803.

    Not in our library10.1371/journal.pone.0147803

  11. 11.

    Balasubramanian S, Uji A, Lei J, Velaga S, Nittala M, Sadda SV, 2017. Interdevice comparison of retinal sensitivity assessments in a healthy population: the CenterVue MAIA and the Nidek MP-3 microperimeters. Br. J. Ophthalmol 102, 109–113..

    Not in our library10.1136/bjophthalmol-2017-310258

  12. 12.

    Barboni MTS, Szepessy Z, Ventura DF, Németh J, 2018. Individual test point fluctuations of macular sensitivity in healthy eyes and eyes with age-related macular degeneration measured with microperimetry. Transl. Vis. Sci. Technol 7, 25..

    Not in our library10.1167/tvst.7.2.25

  13. 13.

    Barteselli G, Bartsch DU, Viola F, Mojana F, Pellegrini M, Hartmann KI, Benatti E, Leicht S, Ratiglia R, Staurenghi G, Weinreb RN, Freeman WR, 2013. Accuracy of the heidelberg spectralis in the alignment between near-infrared image and tomographic scan in a model eye: a multicenter study. Am. J. Ophthalmol 156, 588–592..

    Not in our library10.1016/j.ajo.2013.04.030

  14. 14.

    Bellmann C, Feely M, Crossland MD, Kabanarou SA, Rubin GS, 2004. Fixation stability using central and pericentral fixation targets in patients with age-related macular degeneration. Ophthalmology 111, 2265–2270..

    Not in our library10.1016/j.ophtha.2004.06.019

  15. 15.

    Bjerrum JP, 1889. Om en tilføjelse til den sædvanlige synsfeltundersøgelse samt om synsfeltet ved glaukom. Nord. Ophthalmol. Tidsskr 2, 141–185.

    Not in our library

  16. 16.

    Bolz M, Simader C, Ritter M, Ahlers C, Benesch T, Prünte C, Schmidt-Erfurth U, 2010. Morphological and functional analysis of the loading regimen with intravitreal ranibizumab in neovascular age-related macular degeneration. Br. J. Ophthalmol 94, 185–189..

    Not in our library10.1136/bjo.2008.143974

  17. 17.

    Bowl W, Lorenz B, Jäger M, Friedburg C, 2013. Improving detection of mild loss of retinal light increment sensitivity at the posterior pole with the Microperimeter MP1. Investig. Ophthalmol. Vis. Sci 54, 4666–4674..

    Not in our library10.1167/iovs.12-11241

  18. 18.

    Buckley TMW, Jolly JK, Menghini M, Wood LJ, Nanda A, MacLaren RE, 2020. Test-retest repeatability of microperimetry in patients with retinitis pigmentosa caused by mutations in RPGR. Clin. Exp. Ophthalmol 48, 714–715..

    Not in our library10.1111/ceo.13753

  19. 19.

    Burns SA, Webb TRH, 1995. Optical Generation of the Visual Stimulus. In: Handbook of Optics, Volume I, Fundamentals, Techniques, and Design. McGRAW-HILL, INC., pp. 28.1–28.28

    Not in our library

  20. 20.

    Cassels NK, Wild JM, Margrain TH, Blyth C, Chong V, Acton JH, 2019. Microperimetry in age-related macular degeneration: an evidence-base for pattern deviation probability analysis in microperimetry. Transl. Vis. Sci. Technol 8, 48..

    Not in our library10.1167/tvst.8.6.48

  21. 21.

    Cehajic-Kapetanovic J, Xue K, Martinez-Fernandez de la Camara C, Nanda A, Davies A, Wood LJ, Salvetti AP, Fischer MD, Aylward JW, Barnard AR, Jolly JK, Luo E, Lujan BJ, Ong T, Girach A, Black GCM, Gregori NZ, Davis JL, Rosa PR, Lotery AJ, Lam BL, Stanga PE, MacLaren RE, 2020. Initial results from a first-in-human gene therapy trial on X-linked retinitis pigmentosa caused by mutations in RPGR. Nat. Med 26, 354–359..

    Not in our library10.1038/s41591-020-0763-1

  22. 22.

    Charbel Issa P, Helb HM, Rohrschneider K, Holz FG, Scholl HPN, 2007. Microperimetric assessment of patients with type 2 idiopathic macular telangiectasia. Investig. Ophthalmol. Vis. Sci 48, 3788–3795..

    Not in our library10.1167/iovs.06-1272

  23. 23.

    Charbel Issa P, Gillies MC, Chew EY, Bird AC, Heeren TFC, Peto T, Holz FG, Scholl HPN, 2013. Macular telangiectasia type 2. Prog. Retin. Eye Res 34, 49–77..

    Not in our library10.1016/j.preteyeres.2012.11.002

  24. 24.

    Charng J, Lamey TM, Thompson JA, McLaren TL, Attia MS, McAllister IL, Constable IJ, Mackey DA, De Roach JN, Chen FK, 2020a. Edge of scotoma sensitivity as a microperimetry clinical trial end point in USH2A retinopathy. Transl. Vis. Sci. Technol 9, 9..

    Not in our library10.1167/tvst.9.10.9

  25. 25.

    Charng J, Sanfilippo PG, Attia MS, Dolliver M, Arunachalam S, Chew AL, Wong EN, Mackey DA, Chen FK, 2020b. Interpreting MAIA microperimetry using age- and retinal loci-specific reference thresholds. Transl. Vis. Sci. Technol 9, 19..

    Not in our library10.1167/tvst.9.7.19

  26. 26.

    Chen FK, Patel PJ, Xing W, Bunce C, Egan C, Tufail AT, Coffey PJ, Rubin GS, da Cruz L, 2009. Test-retest variability of microperimetry using the Nidek MP1 in patients with macular disease. Investig. Ophthalmol. Vis. Sci 50, 3464–3472..

    Not in our library10.1167/iovs.08-2926

  27. 27.

    Chen FK, Patel PJ, Webster AR, Coffey PJ, Tufail A, Da Cruz L, 2011. Nidek MP1 is able to detect subtle decline in function in inherited and age-related atrophic macular disease with stable visual acuity. Retina 31, 371–379..

    Not in our library10.1097/iae.0b013e3181e46af3

  28. 28.

    Chen KG, Alvarez JA, Yazdanie M, Papudesu C, Wong WT, Wiley HE, Keenan TD, Chew EY, Ferris FL, Cukras CA, 2019. Longitudinal study of dark adaptation as a functional outcome measure for age-related macular degeneration. Ophthalmology 126, 856–865..

    Not in our library10.1016/j.ophtha.2018.09.039

  29. 29.

    Chew EY, Clemons TE, Jaffe GJ, Johnson CA, Farsiu S, Lad EM, Guymer R, Rosenfeld P, Hubschman JP, Constable I, Wiley H, Singerman LJ, Gillies M, Comer G, Blodi B, Eliott D, Yan J, Bird A, Friedlander M, 2019. Effect of ciliary neurotrophic factor on retinal neurodegeneration in patients with macular telangiectasia type 2: a randomized clinical trial. Ophthalmology 126, 540–549..

    Not in our library10.1016/j.ophtha.2018.09.041

  30. 30.

    Cideciyan AV, Swider M, Aleman TS, Sumaroka A, Schwartz SB, Roman MI, Milam AH, Bennett J, Stone EM, Jacobson SG, 2005. ABCA4-associated retinal degenerations spare structure and function of the human parapapillary retina. Investig. Ophthalmol. Vis. Sci 46, 4739–4746..

    Not in our library10.1167/iovs.05-0805

  31. 31.

    Cideciyan AV, Aleman TS, Boye SL, Schwartz SB, Kaushal S, Roman AJ, Pang JJ, Sumaroka A, Windsor EAM, Wilson JM, Flotte TR, Fishman GA, Heon E, Stone EM, Byrne BJ, Jacobson SG, Hauswirth WW, 2008. Human gene therapy for RPE65 isomerase deficiency activates the retinoid cycle of vision but with slow rod kinetics. Proc. Natl. Acad. Sci. U.S.A 105, 15112–15117..

    Not in our library10.1073/pnas.0807027105

  32. 32.

    Cideciyan AV, Swider M, Aleman TS, Tsybovsky Y, Schwartz SB, Windsor EAM, Roman AJ, Sumaroka A, Steinberg JD, Jacobson SG, Stone EM, Palczewski K, 2009. ABCA4 disease progression and a proposed strategy for gene therapy. Hum. Mol. Genet 18, 931–941..

    Not in our library10.1093/hmg/ddn421

  33. 33.

    Cideciyan AV, Swider M, Aleman TS, Feuer WJ, Schwartz SB, Russell RC, Steinberg JD, Stone EM, Jacobson SG, 2012. Macular function in macular degenerations: repeatability of microperimetry as a potential outcome measure for ABCA4-associated retinopathy trials. Investig. Ophthalmol. Vis. Sci 53, 841–852..

    Not in our library10.1167/iovs.11-8415

  34. 34.

    Cideciyan AV, Roman AJ, Jacobson SG, Yan B, Pascolini M, Charng J, Pajaro S, Nirenberg S, 2016. Developing an outcome measure with high luminance for optogenetics treatment of severe retinal degenerations and for gene therapy of cone diseases. Investig. Ophthalmol. Vis. Sci 57, 3211–3221..

    Not in our library10.1167/iovs.16-19586

  35. 35.

    Cocce KJ, Stinnett SS, Luhmann UFO, Vajzovic L, Horne A, Schuman SG, Toth CA, Cousins SW, Lad EM, 2018. Visual function metrics in early and intermediate dry age-related macular degeneration for use as clinical trial endpoints. Am. J. Ophthalmol 189, 127–138..

    Not in our library10.1016/j.ajo.2018.02.012

  36. 36.

    Comyn O, Sivaprasad S, Peto T, Neveu MM, Holder GE, Xing W, Bunce CV, Patel PJ, Egan CA, Bainbridge JW, Hykin PG, 2014. A randomized trial to assess functional and structural effects of ranibizumab versus laser in diabetic macular edema (the LUCIDATE Study). Am. J. Ophthalmol 157, 960–970..

    Not in our library10.1016/j.ajo.2014.02.019

  37. 37.

    Convento E, Midena E, Dorigo MT, Maritan V, Cavarzeran F, Fregona IA, 2006. Peripapillary fundus perimetry in eyes with glaucoma. Br. J. Ophthalmol 90, 1398–1403..

    Not in our library10.1136/bjo.2006.092973

  38. 38.

    Corvi F, Pellegrini M, Belotti M, Bianchi C, Staurenghi G, 2019. Scotopic and fast mesopic microperimetry in eyes with drusen and reticular pseudodrusen. Retina 39, 2378–2383..

    Not in our library10.1097/iae.0000000000002335

  39. 39.

    Crabb DP, Garway-Heath DF, 2012. Intervals between visual field tests when monitoring the glaucomatous patient: wait-and-see approach. Invest. Ophthalmol. Vis. Sci 53, 2770–2776..

    Not in our library10.1167/iovs.12-9476

  40. 40.

    Crossland M, Rubin GS, 2014. Retinal fixation and microperimetry. In: Midena E (Ed.), Microperimetry and Multimodal Retinal Imaging. Springer Berlin Heidelberg, Berlin, Heidelberg, pp. 5–11..

    Not in our library10.1007/978-3-642-40300-2_2

  41. 41.

    Crossland Michael D., Culham LE, Rubin GS, 2004. Fixation stability and reading speed in patients with newly developed macular disease. Ophthalmic Physiol. Optic 24, 327–333..

    Not in our library10.1111/j.1475-1313.2004.00213.x

  42. 42.

    Crossland MD, Sims M, Galbraith RF, Rubin GS, 2004. Evaluation of a new quantitative technique to assess the number and extent of preferred retinal loci in macular disease. Vis. Res 44, 1537–1546..

    Not in our library10.1016/j.visres.2004.01.006

  43. 43.

    Crossland MD, Culham LE, Kabanarou SA, Rubin GS, 2005. Preferred retinal locus development in patients with macular disease. Ophthalmology 112, 1579–1585..

    Not in our library10.1016/j.ophtha.2005.03.027

  44. 44.

    Crossland MD, Crabb DP, Rubin GS, 2011a. Task-specific fixation behavior in macular disease. Investig. Ophthalmol. Vis. Sci 52, 411–416..

    Not in our library10.1167/iovs.10-5473

  45. 45.

    Crossland MD, Luong VA, Rubin GS, Fitzke FW, 2011b. Retinal specific measurement of dark-adapted visual function: validation of a modified microperimeter. BMC Ophthalmol 11, 5..

    Not in our library10.1186/1471-2415-11-5

  46. 46.

    Crossland MD, Tufail A, Rubin GS, Stockman A, 2012. Mesopic microperimetry measures mainly cones; dark-adapted microperimetry measures rods and cones. Invest. Ophthalmol. Vis. Sci 53, 4822.

    Not in our library

  47. 47.

    Csaky K, Ferris F, Chew EY, Nair P, Cheetham JK, Duncan JL, 2017. Report from the NEI/FDA endpoints workshop on age- related macular degeneration and inherited retinal diseases. Investig. Ophthalmol. Vis. Sci 58, 3456–3463..

    Not in our library10.1167/iovs.17-22339

  48. 48.

    Csaky KG, Patel PJ, Sepah YJ, Birch DG, Do DV, Ip MS, Guymer RH, Luu CD, Gune S, Lin H, Ferrara D, 2019. Microperimetry for geographic atrophy secondary to age-related macular degeneration. Surv. Ophthalmol 64, 353–364..

    Not in our library10.1016/j.survophthal.2019.01.014

  49. 49.

    Cummings RW, Whittaker SG, Watson GR, Budd JM, 1985. Scanning characters and reading with a central scotoma. Optom. Vis. Sci 62, 833–843..

    Not in our library10.1097/00006324-198512000-00004

  50. 50.

    Curcio CA, McGwin G, Sadda SR, Hu Z, Clark ME, Sloan KR, Swain T, Crosson JN, Owsley C, 2020. Functionally validated imaging endpoints in the Alabama study on early age-related macular degeneration 2 (ALSTAR2): design and methods. BMC Ophthalmol 20, 196..

    Not in our library10.1186/s12886-020-01467-0

  51. 51.

    De Moraes CG, Liebmann JM, Levin LA, 2017. Detection and measurement of clinically meaningful visual field progression in clinical trials for glaucoma. Prog. Retin. Eye Res 56, 107–147..

    Not in our library10.1016/j.preteyeres.2016.10.001

  52. 52.

    Deák GG, Bolz M, Ritter M, Prager S, Benesch T, Schmidt-Erfurth U, 2010. A systematic correlation between morphology and functional alterations in diabetic macular edema. Investig. Ophthalmol. Vis. Sci 51, 6710–6714..

    Not in our library10.1167/iovs.09-5064

  53. 53.

    Demirel S, Johnson CA, 2000. Isolation of short-wavelength sensitive mechanisms in normal and glaucomatous visual field regions. J. Glaucoma 9, 63–73..

    Not in our library10.1097/00061198-200002000-00012

  54. 54.

    Denniss J, Astle AT, 2016. Spatial interpolation enables normative data comparison in gaze-contingent microperimetry. Investig. Ophthalmol. Vis. Sci 57, 5449–5456..

    Not in our library10.1167/iovs.16-20222

  55. 55.

    Denniss J, Baggaley HC, Brown GM, Rubin GS, Astle AT, 2017. Properties of visual field defects around the monocular preferred retinal locus in age-related macular degeneration. Investig. Ophthalmol. Vis. Sci 58, 2652–2658..

    Not in our library10.1167/iovs.16-21086

  56. 56.

    Denniss J, Baggaley HC, Astle AT, 2018. Predicting visual acuity from visual field sensitivity in age-related macular degeneration. Investig. Ophthalmol. Vis. Sci 59, 4590–4597..

    Not in our library10.1167/iovs.18-24861

  57. 57.

    Dimopoulos IS, Tseng C, Macdonald IM, 2016. Microperimetry as an outcome measure in choroideremia trials: reproducibility and beyond. Investig. Ophthalmol. Vis. Sci 57, 4151–4161..

    Not in our library10.1167/iovs.16-19338

  58. 58.

    Dimopoulos IS, Freund PR, Knowles JA, Macdonald IM, 2018a. The natural history of full-field stimulus threshold decline in choroideremia. Retina 38, 1731–1742..

    Not in our library10.1097/iae.0000000000001764

  59. 59.

    Dimopoulos IS, Hoang SC, Radziwon A, Binczyk NM, Seabra MC, MacLaren RE, Somani R, Tennant MTS, MacDonald IM, 2018b. Two-year results after AAV2-mediated gene therapy for choroideremia: the alberta experience. Am. J. Ophthalmol 193, 130–142..

    Not in our library10.1016/j.ajo.2018.06.011

  60. 60.

    Domdei N, Domdei L, Reiniger JL, Linden M, Holz FG, Roorda A, Harmening WM, 2018. Ultra-high contrast retinal display system for single photoreceptor psychophysics. Biomed. Optic Express 9, 157..

    Not in our library10.1364/boe.9.000157

  61. 61.

    Drasdo N, Millican CL, Katholi CR, Curcio CA, 2007. The length of Henle fibers in the human retina and a model of ganglion receptive field density in the visual field. Vis. Res 47, 2901–2911..

    Not in our library10.1016/j.visres.2007.01.007

  62. 62.

    Dunbar HMP, Crossland MD, Rubin GS, 2010. Fixation stability: a comparison between the nidek MP-1 and the roden stock scanning laser ophthalmoscope in persons with and without diabetic maculopathy. Investig. Ophthalmol. Vis. Sci 51, 4346–4350..

    Not in our library10.1167/iovs.09-4556

  63. 63.

    Duret F, Issenhuth M, Safran AB, 1999. Combined use of several preferred retinal loci in patients with macular disorders when reading single words. Vis. Res 39, 873–879..

    Not in our library10.1016/s0042-6989(98)00179-5

  64. 64.

    Durlach PJ, 2004. Change blindness and its implications for complex monitoring and control systems design and operator training. Hum. Comput. Interact 19, 423–451..

    Not in our library10.1207/s15327051hci1904_10

  65. 65.

    Eandi CM, Piccolino FC, Alovisi C, Tridico F, Giacomello D, Grignolo FM, 2015. Correlation between fundus autofluorescence and central visual function in chronic central serous chorioretinopathy. Am. J. Ophthalmol 159, 652–658. e1.

    Not in our library10.1016/j.ajo.2014.12.023

  66. 66.

    Echols BS, Clark ME, Swain TA, Chen L, Kar D, Zhang Y, Sloan KR, McGwin GJ, Singireddy R, Mays C, Kilpatrick D, Crosson JN, Owsley C, Curcio CA, 2020. Hyperreflective foci and specks are associated with delayed rod-mediated dark adaptation in nonneovascular age-related macular degeneration. Ophthalmol. Retin.

    Not in our library10.1016/j.oret.2020.05.001

  67. 67.

    Edwards TL, Groppe M, Jolly JK, Downes SM, Maclaren RE, 2015. Correlation of retinal structure and function in choroideremia carriers. Ophthalmology 122, 1274–1276..

    Not in our library10.1016/j.ophtha.2014.12.036

  68. 68.

    Ernst W, Faulkner DJ, Hogg CR, Powell DJ, Arden GB, Vaegan, 1983. An automated statis perimeter/adaptometer using light emitting diodes. Br. J. Ophthalmol 67, 431–442..

    Not in our library10.1136/bjo.67.7.431

  69. 69.

    Ervin AM, Strauss RW, Ahmed MI, Birch D, Cheetham J, Ferris FL, Ip MS, Jaffe GJ, Maguire MG, Schönbach EM, Sadda SR, West SK, Scholl HPN, 2019. A workshop on measuring the progression of atrophy secondary to stargardt disease in the progstar studies: findings and lessons learned. Transl. Vis. Sci. Technol 8, 16..

    Not in our library10.1167/tvst.8.2.16

  70. 70.

    European Glaucoma Society, 2017. European glaucoma society terminology and guidelines for glaucoma, 4th edition - Part 1supported by the EGS foundation. Br. J. Ophthalmol 101, 1–72..

    Not in our library10.1136/bjophthalmol-2016-egsguideline.001

  71. 71.

    Fang PP, Pfau M, Holz FG, Finger RP, 2017. Persistent visual loss in dengue fever due to outer retinal damage. Clin. Exp. Ophthalmol 45, 747–749..

    Not in our library10.1111/ceo.12960

  72. 72.

    Ferree CE, Rand G, 1922. An illuminated perimeter with campimeter features. Am. J. Ophthalmol 5, 455–465..

    Not in our library10.1016/s0002-9394(22)90403-9

  73. 73.

    Finger RP, Schmitz-Valckenberg S, Schmid M, Rubin GS, Dunbar H, Tufail A, Crabb DP, Binns A, Sánchez CI, Margaron P, Normand G, Durbin MK, Luhmann UFO, Zamiri P, Cunha-Vaz J, Asmus F, Holz FG, 2019. MACUSTAR: development and clinical validation of functional, structural, and patient-reported endpoints in intermediate age-related macular degeneration. Ophthalmologica 241, 61–72..

    Not in our library10.1159/000491402

  74. 74.

    Fischer MD, Ochakovski GA, Beier B, Seitz IP, Vaheb Y, Kortuem C, Reichel FFL, Kuehlewein L, Kahle NA, Peters T, Girach A, Zrenner E, Ueffing M, Maclaren RE, Bartz-Schmidt K, Wilhelm B, 2020. CHANGES in RETINAL SENSITIVITY after GENE THERAPY in CHOROIDEREMIA. Retina 40, 160–168..

    Not in our library10.1097/iae.0000000000002360

  75. 75.

    Flammer J, Drance SM, Augustiny L, Funkhouser A, 1985. Quantification of glaucomatous visual field defects with automated perimetry. Investig. Ophthalmol. Vis. Sci 26, 176–181.

    Not in our library

  76. 76.

    Fleckenstein M, Charbel Issa P, Fuchs HA, Finger RP, Helb HM, Scholl HPN, Holz FG, 2009. Discrete arcs of increased fundus autofluorescence in retinal dystrophies and functional correlate on microperimetry. Eye 23, 567–575..

    Not in our library10.1038/eye.2008.59

  77. 77.

    Fletcher DC, Schuchard RA, 1997. Preferred retinal loci relationship to macular scotomas in a low-vision population. Ophthalmology 104, 632–638..

    Not in our library10.1016/s0161-6420(97)30260-7

  78. 78.

    Foote KG, Rinella N, Tang J, Bensaid N, Zhou H, Zhang Q, Wang RK, Porco TC, Roorda A, Duncan JL, 2019. Cone structure persists beyond margins of short-wavelength autofluorescence in choroideremia. Investig. Ophthalmol. Vis. Sci 60, 4931–4942..

    Not in our library10.1167/iovs.19-27979

  79. 79.

    Förster CFR, 1869. Vorzeigung des Perimeter. Klin. Monbl. Augenheilkd 411–422.

    Not in our library

  80. 80.

    Fuchs AF, 1967. Saccadic and smooth pursuit eye movements in the monkey. J. Physiol 191, 609–631..

    Not in our library10.1113/jphysiol.1967.sp008271

  81. 81.

    Fujii GY, De Juan E, Sunness J, Humayun MS, Pieramici DJ, Chang TS, 2002. Patient selection for macular translocation surgery using the scanning laser ophthalmoscope. Ophthalmology 109, 1737–1744..

    Not in our library10.1016/s0161-6420(02)01120-x

  82. 82.

    Fujino R, Asaoka R, Aoki S, Sugiura A, Kusakabe M, Asano-Shimizu K, Nomura Y, Aoki A, Hashimoto Y, Azuma K, Inoue T, Obata R, 2020. The usefulness of the retinal sensitivity measurement with a microperimetry for predicting the visual prognosis of branch retinal vein occlusion with macular edema. Graefe’s Arch. Clin. Exp. Ophthalmol. = Albr. von Graefes Arch. fur Klin. und Exp. Ophthalmol 258, 1949–1958..

    Not in our library10.1007/s00417-020-04759-9

  83. 83.

    Fujita K, Shinoda K, Imamura Y, Matsumoto CS, Mizutani Y, Mizota A, Yuzawa M, 2012. Correlation of integrity of cone outer segment tips line with retinal sensitivity after half-dose photodynamic therapy for chronic central serous chorioretinopathy. Am. J. Ophthalmol 154, 579–585..

    Not in our library10.1016/j.ajo.2012.03.043

  84. 84.

    Funatsu J, Murakami Y, Nakatake S, Akiyama M, Fujiwara K, Shimokawa S, Tachibana T, Hisatomi T, Koyanagi Y, Momozawa Y, Sonoda K-H, Ikeda Y, 2019. Direct comparison of retinal structure and function in retinitis pigmentosa by co-registering microperimetry and optical coherence tomography. PloS One 14. e0226097–e0226097.

    Not in our library10.1371/journal.pone.0226097

  85. 85.

    Gaffney AJ, Margrain TH, Bunce CV, Binns AM, 2014. How effective is eccentric viewing training? A systematic literature review. Ophthalmic Physiol. Optic 34, 427–437..

    Not in our library10.1111/opo.12132

  86. 86.

    Garafalo AV, Cideciyan AV, Héon E, Sheplock R, Pearson A, WeiYang Yu C, Sumaroka A, Aguirre GD, Jacobson SG, 2020. Progress in treating inherited retinal diseases: early subretinal gene therapy clinical trials and candidates for future initiatives. Prog. Retin. Eye Res 77, 100827., 100827.

    Not in our library10.1016/j.preteyeres.2019.100827

  87. 87.

    Garway-Heath DF, Crabb DP, Bunce C, Lascaratos G, Amalfitano F, Anand N, Azuara-Blanco A, Bourne RR, Broadway DC, Cunliffe IA, Diamond JP, Fraser SG, Ho TA, Martin KR, McNaught AI, Negi A, Patel K, Russell RA, Shah A, Spry PG, Suzuki K, White ET, Wormald RP, Xing W, Zeyen TG, 2015. Latanoprost for open-angle glaucoma (UKGTS): a randomised, multicentre, placebo-controlled trial. Lancet 385, 1295–1304..

    Not in our library10.1016/s0140-6736(14)62111-5

  88. 88.

    Gerendas BS, Kroisamer JS, Buehl W, Rezar-Dreindl SM, Eibenberger KM, Pablik E, Schmidt-Erfurth U, Sacu S, 2018. Correlation between morphological characteristics in spectral-domain-optical coherence tomography, different functional tests and a patient’s subjective handicap in acute central serous chorioretinopathy. Acta Ophthalmol 96, e776–e782..

    Not in our library10.1111/aos.13665

  89. 89.

    Glen FC, Baker H, Crabb DP, 2014. A qualitative investigation into patients’ views on visual field testing for glaucoma monitoring. BMJ Open 4, 1–10..

    Not in our library10.1136/bmjopen-2013-003996

  90. 90.

    Goldmann H, 1945. Grundlagen exakter perimetrie. Ophthalmologica 109, 57–70.

    Not in our library

  91. 91.

    Goldmann H, 1946. Demonstration unseres neuen Projektionskugelperimeters samt theoretischen und klinischen Bemerkungen über Perimetrie. Ophthalmologica 111, 187–192..

    Not in our library10.1159/000300322

  92. 92.

    Von Graefe A, 1856. Ueber die Untersuchung des Gesichtsfeldes bei amblyopischen Affectionen. Arch. für Opthalmologie 2, 258–298..

    Not in our library10.1007/bf02720669

  93. 93.

    Greenstein VC, Duncker T, Holopigian K, Carr RE, Greenberg JP, Tsang SH, Hood DC, 2012. Structural and functional changes associated with normal and abnormal fundus autofluorescence in patients with retinitis pigmentosa. Retina 32, 349–357..

    Not in our library10.1097/iae.0b013e31821dfc17

  94. 94.

    Han RC, Jolly JK, Xue K, MacLaren RE, 2017. Effects of pupil dilation on MAIA microperimetry. Clin. Exp. Ophthalmol 45, 489–495..

    Not in our library10.1111/ceo.12907

  95. 95.

    Han RC, Gray JM, Han J, MacLaren RE, Jolly JK, 2019. Optimisation of dark adaptation time required for mesopic microperimetry. Br. J. Ophthalmol 103, 1092–1098..

    Not in our library10.1136/bjophthalmol-2018-312253

  96. 96.

    Hariri AH, Tepelus TC, Akil H, Nittala MG, Sadda SR, 2016. Retinal sensitivity at the junctional zone of eyes with geographic atrophy due to age-related macular degeneration. Am. J. Ophthalmol 168, 122–128..

    Not in our library10.1016/j.ajo.2016.05.007

  97. 97.

    Harmening WM, Tuten WS, Roorda A, Sincich LC, 2014. Mapping the perceptual grain of the human retina. J. Neurosci 34, 5667–5677..

    Not in our library10.1523/jneurosci.5191-13.2014

  98. 98.

    Hartmann KI, Bartsch DUG, Cheng L, Kim JS, Gomez ML, Klein H, Freeman WR, 2011. Scanning laser ophthalmoscope imaging stabilized microperimetry in dry age-related macular degeneration. Retina 31, 1323–1331..

    Not in our library10.1097/iae.0b013e31820a6850

  99. 99.

    Heeren TFC, Clemons T, Scholl HPN, Bird AC, Holz FG, Issa PC, 2015. Progression of vision loss in macular telangiectasia type 2. Investig. Ophthalmol. Vis. Sci 56, 3905–3912..

    Not in our library10.1167/iovs.15-16915

  100. 100.

    Heeren TFC, Kitka D, Florea D, Clemons TE, Chew EY, Bird AC, Pauleikhoff D, Issa PC, Holz FG, Peto T, 2017. Longitudinal correlation of ellipsoid zone loss and functional loss in macular telangiectasia type 2. Retina 38 Suppl 1, S20–S26..

    Not in our library10.1097/iae.0000000000001715

  101. 101.

    Heeren TFC, Tzaridis S, Bonelli R, Pfau M, Fruttiger M, Okada M, Egan C, Issa PC, Holz FG, 2019. Dark-adapted two-color fundus-controlled perimetry in macular telangiectasia type 2. Investig. Ophthalmol. Vis. Sci 60, 1760–1767..

    Not in our library10.1167/iovs.18-25360

  102. 102.

    Heier JS, Pieramici D, Chakravarthy U, Patel SS, Gupta S, Lotery A, Lad EM, Silverman D, Henry EC, Anderesi M, Tschosik EA, Gray S, Ferrara D, Guymer R, 2020. Visual function decline resulting from geographic atrophy: results from the chroma and spectri phase 3 trials. Ophthalmol. Retin 4, 673–688..

    Not in our library10.1016/j.oret.2020.01.019

  103. 103.

    Heijl A, Krakau C, 1975. An automatic static perimeter, design and pilot study. Acta Ophthalmol 53, 293–310..

    Not in our library10.1111/j.1755-3768.1975.tb01161.x

  104. 104.

    Heijl A, Lindgren G, Olsson J, 1987a. A package for the statistical analysis of visual fields, in: Seventh International Visual Field Symposium, Amsterdam, September 1986. Springer, pp. 153–168..

    Not in our library10.1007/978-94-009-3325-5_23

  105. 105.

    Heijl Anders, Lindgren G, Olsson J, 1987b. Reliability parameters in computerized perimetry. In: Greve EL, Heijl A ((Eds.). Springer Netherlands, Dordrecht, pp. 593–600..

    Not in our library10.1007/978-94-009-3325-5_75

  106. 106.

    Helmholtz H, 1851. Beschreibung eines augen-spiegels, beschreibung eines augen-spiegels. Springer, Berlin, Heidelberg..

    Not in our library10.1007/978-3-662-41295-4

  107. 107.

    Hirooka K, Misaki K, Nitta E, Ukegawa K, Sato S, Tsujikawa A, 2016. Comparison of macular integrity assessment (MAIA ™), MP-3, and the humphrey field analyzer in the evaluation of the relationship between the structure and function of the Macula. PloS One 11. e0151000.

    Not in our library10.1371/journal.pone.0151000

  108. 108.

    Holz FG, Sadda SR, Busbee B, Chew EY, Mitchell P, Tufail A, Brittain C, Ferrara D, Gray S, Honigberg L, Martin J, Tong B, Ehrlich JS, Bressler NM, 2018. Efficacy and safety of lampalizumab for geographic atrophy due to age-related macular degeneration: chroma and spectri phase 3 randomized clinical trials. JAMA Ophthalmol 136, 666–677..

    Not in our library10.1001/jamaophthalmol.2018.1544

  109. 109.

    Hood DC, Ramachandran R, Holopigian K, Lazow M, Birch DG, Greenstein VC, 2011. Method for deriving visual field boundaries from OCT scans of patients with retinitis pigmentosa. Biomed. Optic Express 2, 1106..

    Not in our library10.1364/boe.2.001106

  110. 110.

    Hsu ST, Thompson AC, Stinnett SS, Luhmann UFO, Vajzovic L, Horne A, Schuman SG, Toth CA, Cousins SW, Lad EM, 2019. Longitudinal study of visual function in dry age-related macular degeneration at 12 months. Ophthalmol. Retin 3, 637–648..

    Not in our library10.1016/j.oret.2019.03.010

  111. 111.

    Iftikhar M, Kherani S, Kaur R, Lemus M, Nefalar A, Usmani B, Junaid N, Campochiaro PA, Scholl HPN, Shah SM, 2018. Progression of retinitis pigmentosa as measured on microperimetry: the PREP-1 study. Ophthalmol. Retin 2, 502–507..

    Not in our library10.1016/j.oret.2017.09.008

  112. 112.

    Issa PC, Singh MS, Lipinski DM, Chong NV, Delori FC, Barnard AR, MacLaren RE, 2012. Optimization of in vivo confocal autofluorescence imaging of the ocular fundus in mice and its application to models of human retinal degeneration. Investig. Ophthalmol. Vis. Sci 53, 1066–1075..

    Not in our library10.1167/iovs.11-8767

  113. 113.

    Jacobson SG, Voigt WJ, Parel JM, Apathy PP, Nghiem-Phu L, Myers SW, Patella VM, 1986. Automated light- and dark- adapted perimetry for evaluating retinitis pigmentosa. Ophthalmology 93, 1604–1611..

    Not in our library10.1016/s0161-6420(86)33522-x

  114. 114.

    Johnson CA, Adams CW, Lewis RA, 1988. Fatigue effects in automated perimetry. Appl. Optic 27, 1030..

    Not in our library10.1364/ao.27.001030

  115. 115.

    Jolly JK, Xue K, Edwards TL, Groppe M, MacLaren RE, 2017. Characterizing the natural history of visual function in choroideremia using microperimetry and multimodal retinal imaging. Investig. Ophthalmol. Vis. Sci 58, 5575–5583..

    Not in our library10.1167/iovs.17-22486

  116. 116.

    Jolly JK, Couldridge-Smith CE, Xue K, Maclaren RE, 2019. The impact of progressive visual field constriction on reading ability in an inherited retinal degeneration. Ophthalmologica 243, 207–216..

    Not in our library10.1159/000503294

  117. 117.

    Jones PR, Yasoubi N, Nardini M, Rubin GS, 2016. Feasibility of macular integrity assessment (Maia) microperimetry in children: sensitivity, reliability, and fixation stability in healthy observers. Investig. Ophthalmol. Vis. Sci 57, 6349–6359..

    Not in our library10.1167/iovs.16-20037

  118. 118.

    Josan AS, Wood TMW, Buckley Laura J, Jolly JK, Cehajic-Kapetanovic J, MacLaren RE, 2020. Microperimetry hill of vision and volumetric measures of retinal sensitivity. Transl. Vis. Sci. Technol [In Revisi.

    Not in our library10.1167/tvst.10.7.12

  119. 119.

    Kani K, 1977. Perimetry under Television Ophthalmoscopy. In: Documenta Ophthalmologica Proceedings Series, pp. 231–236.

    Not in our library

  120. 120.

    Kani K, Ogita Y, 1979. Fundus controlled perimetry. Folia Ophthalmol. Jpn 30, 141–147..

    Not in our library10.1007/978-94-009-9611-3_37

  121. 121.

    Khuu SK, Kalloniatis M, 2015a. Spatial summation across the central visual field: implications for visual field testing. J. Vis 15, 15–16..

    Not in our library10.1167/15.1.6

  122. 122.

    Khuu SK, Kalloniatis M, 2015b. Standard automated perimetry: determining spatial summation and its effect on contrast sensitivity across the visual field. Invest. Ophthalmol. Vis. Sci 56, 3565–3576..

    Not in our library10.1167/iovs.14-15606

  123. 123.

    Kihara Y, Heeren TFC, Lee CS, Wu Y, Xiao S, Tzaridis S, Holz FG, Charbel Issa P, Egan CA, Lee AY, 2019. Estimating retinal sensitivity using optical coherence tomography with deep-learning algorithms in macular telangiectasia type 2. JAMA Netw. open 2. e188029.

    Not in our library10.1001/jamanetworkopen.2018.8029

  124. 124.

    Klewin KM, Radius RL, 1986. Background illumination and automated perimetry. Arch. Ophthalmol 104, 395–397..

    Not in our library10.1001/archopht.1986.01050150095035

  125. 125.

    Kriechbaum K, Prager F, Geitzenauer W, Benesch T, Schütze C, Simader C, Schmidt-Erfurth U, 2009. Association of retinal sensitivity and morphology during antiangiogenic treatment of retinal vein occlusion over one year. Ophthalmology 116, 2415–2421..

    Not in our library10.1016/j.ophtha.2009.05.001

  126. 126.

    Lamb TD, Pugh EN, 2004. Dark adaptation and the retinoid cycle of vision. Prog. Retin. Eye Res 23, 307–380..

    Not in our library10.1016/j.preteyeres.2004.03.001

  127. 127.

    Landa G, Su E, Garcia PMT, Seiple WH, Rosen RB, 2011. Inner segment-outer segment junctional layer integrity and corresponding retinal sensitivity in dry and wet forms of age-related macular degeneration. Retina 31, 364–370..

    Not in our library10.1097/iae.0b013e3181e91132

  128. 128.
  129. 129.

    Lei H, Schuchard RA, 1997. Using two preferred retinal loci for different lighting conditions in patients with central scotomas. Investig. Ophthalmol. Vis. Sci 38, 1812–1818.

    Not in our library

  130. 130.

    Lim LS, Mitchell P, Seddon JM, Holz FG, Wong TY, 2012. Age-related macular degeneration. Lancet 379, 1728–1738..

    Not in our library10.1016/s0140-6736(12)60282-7

  131. 131.

    Lindner M, Nadal J, Mauschitz MM, Lüning A, Czauderna J, Pfau M, Schmitz-Valckenberg S, Holz FG, Schmid M, Fleckenstein M, 2017. Combined fundus autofluorescence and near infrared reflectance as prognostic biomarkers for visual acuity in foveal-sparing geographic atrophy. Investig. Ophthalmol. Vis. Sci 58, BIO61–BIO67..

    Not in our library10.1167/iovs.16-21210

  132. 132.

    Lisboa R, Weinreb RN, Medeiros FA, 2013. Combining structure and function to evaluate glaucomatous progression: implications for the design of clinical trials. Curr. Opin. Pharmacol 13, 115–122..

    Not in our library10.1016/j.coph.2012.10.010

  133. 133.

    Liu H, Bittencourt MG, Wang J, Sophie R, Annam R, Ibrahim MA, Sepah YJ, Moradi A, Scholl HPN, Nguyen QD, 2014. Assessment of central retinal sensitivity employing two types of microperimetry devices. Transl. Vis. Sci. Technol 3, 3..

    Not in our library10.1167/tvst.3.5.3

  134. 134.

    Liu H, Bittencourt MG, Sophie R, Sepah YJ, Hanout M, Rentiya Z, Annam R, Scholl HPN, Nguyen QD, 2015. Fixation stability measurement using two types of microperimetry devices. Transl. Vis. Sci. Technol 4, 3..

    Not in our library10.1167/tvst.4.2.3

  135. 135.

    Longhin E, Convento E, Pilotto E, Bonin G, Vujosevic S, Kotsafti O, Midena E, 2013. Static and dynamic retinal fixation stability in microperimetry. Can. J. Ophthalmol 48, 375–380..

    Not in our library10.1016/j.jcjo.2013.05.021

  136. 136.
  137. 137.

    Luu CD, Tan R, Caruso E, Fletcher EL, Lamb TD, Guymer RH, 2018. Topographic rod recovery profiles after a prolonged dark adaptation in subjects with reticular pseudodrusen. Ophthalmol. Retin 2, 1206–1217..

    Not in our library10.1016/j.oret.2018.06.016

  138. 138.

    MacLaren RE, Groppe M, Barnard AR, Cottriall CL, Tolmachova T, Seymour L, Reed Clark K, During MJ, Cremers FPM, Black GCM, Lotery AJ, Downes SM, Webster AR, Seabra MC, 2014. Retinal gene therapy in patients with choroideremia: initial fi ndings from a phase 1/2 clinical trial. Lancet 383, 1129–1137..

    Not in our library10.1016/s0140-6736(13)62117-0

  139. 139.

    Mallery RM, Poolman P, Thurtell MJ, Wang J-K, Garvin MK, Ledolter J, Kardon RH, 2016. The pattern of visual fixation eccentricity and instability in optic neuropathy and its spatial relationship to retinal ganglion cell layer thickness. Invest. Ophthalmol. Vis. Sci 57, OCT429–O437..

    Not in our library10.1167/iovs.15-18916

  140. 140.

    Martin Bland J, Altman DG, 1986. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 327, 307–310..

    Not in our library10.1016/s0140-6736(86)90837-8

  141. 141.

    Martínez-Costa L, Victoria Ibañez M, Murcia-Bello C, Epifanio I, Verdejo-Gimeno C, Beltrán-Catalán E, Marco-Ventura P, 2013. Use of microperimetry to evaluate hydroxychloroquine and chloroquine retinal toxicity. Can. J. Ophthalmol 48, 400–405..

    Not in our library10.1016/j.jcjo.2013.03.018

  142. 142.

    McGuigan DB, Roman AJ, Cideciyan AV, Matsui R, Gruzensky ML, Sheplock R, Jacobson SG, 2016. Automated light- and dark-adapted perimetry for evaluating retinitis pigmentosa: filling a need to accommodate multicenter clinical trials. Investig. Ophthalmol. Vis. Sci 57, 3118–3128..

    Not in our library10.1167/iovs.16-19302

  143. 143.

    McKendrick AM, Zeman A, Liu P, Aktepe D, Aden I, Bhagat D, Do K, Nguyen HD, Turpin A, 2019. Robot assistants for perimetry: a study of patient experience and performance. Transl. Vis. Sci. Technol 8, 59..

    Not in our library10.1167/tvst.8.3.59

  144. 144.

    Medeiros FA, 2017. Biomarkers and surrogate endpoints: lessons learned from glaucoma. Investig. Ophthalmol. Vis. Sci 58, BIO20–BIO26..

    Not in our library10.1167/iovs.17-21987

  145. 145.

    Medeiros FA, Weinreb RN, Moore G, Liebmann JM, Girkin CA, Zangwill LM, 2012. Integrating event- and trend-based analyses to improve detection of glaucomatous visual field progression. Ophthalmology 119, 458–467..

    Not in our library10.1016/j.ophtha.2011.10.003

  146. 146.
  147. 147.

    Meleth AD, Mettu P, Agrón E, Chew EY, Sadda SR, Ferris FL, Wong WT, 2011. Changes in retinal sensitivity in geographic atrophy progression as measured by microperimetry. Investig. Ophthalmol. Vis. Sci 52, 1119–1126..

    Not in our library10.1167/iovs.10-6075

  148. 148.

    Meyers MP, 1959. The use of the visuscope; for mapping a field of retinal function. Am. J. Ophthalmol 47, 677–681..

    Not in our library10.1016/s0002-9394(14)78194-2

  149. 149.

    Midena E, 2014. Microperimetry and multimodal retinal imaging, microperimetry and multimodal retinal imaging. Springer..

    Not in our library10.1007/978-3-642-40300-2

  150. 150.

    Midena E, Pilotto E, 2013. Microperimetry. Age-related macular degener. 173–187..

    Not in our library10.1007/978-3-642-22107-1_11

  151. 151.

    Midena E, Radin PP, Pilotto E, Ghirlando A, Convento E, Varano M, 2004. Fixation pattern and macular sensitivity in eyes with subfoveal choroidal neovascularization secondary to age-related macular degeneration. A microperimetry study. Semin. Ophthalmol 19, 55–61..

    Not in our library10.1080/08820530490882896

  152. 152.

    Midena E, Vujosevic S, Cavarzeran F, Luciani F, Cappello E, Tollot L, Carpineto P, Capris P, Convento E, Radin PP, Varano M, Tedeschi E, Parodi MB, 2010. Normal values for fundus perimetry with the microperimeter MP1. Ophthalmology 117, 1571–1576. e1.

    Not in our library10.1016/j.ophtha.2009.12.044

  153. 153.

    Montesano G, Crabb DP, Jones PR, Fogagnolo P, Digiuni M, Rossetti LM, 2018. Evidence for alterations in fixational eye movements in glaucoma. BMC Ophthalmol 18, 191..

    Not in our library10.1186/s12886-018-0870-7

  154. 154.

    Montesano G, Bryan SR, Crabb DP, Fogagnolo P, Oddone F, McKendrick AM, Turpin A, Lanzetta P, Perdicchi A, Johnson CA, Garway-Heath DF, Brusini P, Rossetti LM, 2019. A comparison between the Compass fundus perimeter and the humphrey field analyzer. Ophthalmology 126, 242–251..

    Not in our library10.1016/j.ophtha.2018.08.010

  155. 155.

    Montesano G, Rossetti LM, McKendrick AM, Turpin A, Fogagnolo P, Oddone F, Lanzetta P, Perdicchi A, Johnson CA, Brusini P, Garway-Heath DF, Crabb DP, 2020. Effect of fundus tracking on structure-function relationship in glaucoma. Br. J. Ophthalmol.

    Not in our library10.1136/bjophthalmol-2019-315070

  156. 156.

    Morales MU, Saker S, Mehta RL, Rubinstein M, Amoaku WM, 2013. Preferred retinal locus profile during prolonged fixation attempts. Can. J. Ophthalmol 48, 368–374..

    Not in our library10.1016/j.jcjo.2013.05.022

  157. 157.

    Morales MU, Saker S, Amoaku WM, 2015. Bilateral eccentric vision training on pseudovitelliform dystrophy with microperimetry biofeedback. BMJ Case Rep, 2015.

    Not in our library10.1136/bcr-2014-207969

  158. 158.

    Morales MU, Saker S, Wilde C, Pellizzari C, Pallikaris A, Notaroberto N, Rubinstein M, Rui C, Limoli P, Smolek MK, Amoaku WM, 2016. Reference clinical database for fixation stability metrics in normal subjects measured with the MAIA microperimeter. Transl. Vis. Sci. Technol 5, 6..

    Not in our library10.1167/tvst.5.6.6

  159. 159.

    Morales MU, Saker S, Wilde C, Rubinstein M, Limoli P, Amoaku WM, 2020. Biofeedback fixation training method for improving eccentric vision in patients with loss of foveal function secondary to different maculopathies. Int. Ophthalmol 40, 305–312..

    Not in our library10.1007/s10792-019-01180-y

  160. 160.

    Mukherjee D, Lad EM, Vann RR, Jaffe SJ, Clemons TE, Friedlander M, Chew EY, Jaffe GJ, Farsiu S, 2017. Correlation between macular integrity assessment and optical coherence tomography imaging of ellipsoid zone in macular telangiectasia type 2. Invest. Ophthalmol. Vis. Sci 58, BIO291–BIO299..

    Not in our library10.1167/iovs.17-21834

  161. 161.

    Müller PL, Pfau M, Mauschitz MM, Möller PT, Birtel J, Chang P, Gliem M, Schmitz-Valckenberg S, Fleckenstein M, Holz FG, Herrmann P, 2018. Comparison of green versus blue fundus autofluorescence in abca4-related retinopathy. Transl. Vis. Sci. Technol 7, 13..

    Not in our library10.1167/tvst.7.5.13

  162. 162.

    Nittala MG, Velaga SB, Hariri A, Pfau M, Birch DG, Haines J, Pericak-Vance MA, Stambolian D, Sadda SVR, 2019. Retinal sensitivity using microperimetry in age-related macular degeneration in an amish population. Ophthalmic Surg. Lasers Imaging Retin 50, E236–E241..

    Not in our library10.3928/23258160-20190905-15

  163. 163.

    Olsson J, Bengtsson B, Heijl A, Rootzén H, 1997. An improved method to estimate frequency of false positive answers in computerized perimetry. Acta Ophthalmol. Scand 75, 181–183..

    Not in our library10.1111/j.1600-0420.1997.tb00120.x

  164. 164.

    Owsley C, McGwin G, Jackson GR, Kallies K, Clark M, 2007. Cone- and rod-mediated dark adaptation impairment in age-related maculopathy. Ophthalmology 114, 1728–1735..

    Not in our library10.1016/j.ophtha.2006.12.023

  165. 165.

    Parker MA, Choi D, Erker LR, Pennesi ME, Yang P, Chegarnov EN, Steinkamp PN, Schlechter CL, Dhaenens C-M, Mohand-Said S, Audo I, Sahel J, Weleber RG, Wilson DJ, 2016. Test-retest variability of functional and structural parameters in patients with stargardt disease participating in the SAR422459 gene therapy trial. Transl. Vis. Sci. Technol 5, 10..

    Not in our library10.1167/tvst.5.5.10

  166. 166.

    Pfau M, Lindner M, Fleckenstein M, Finger RP, Rubin GS, Harmening WM, Morales MU, Holz FG, Schmitz-Valckenberg S, 2017a. Test-retest reliability of scotopic and mesopic fundus-controlled perimetry using a modified MAIA (macular integrity assessment) in normal eyes. Ophthalmologica 237, 42–54..

    Not in our library10.1159/000453079

  167. 167.

    Pfau M, Lindner M, Müller PL, Birtel J, Finger RP, Harmening WM, Fleckenstein M, Holz FG, Schmitz-Valckenberg S, 2017b. Effective dynamic range and retest reliability of dark-adapted two-color fundus-controlled perimetry in patients with macular diseases. Invest. Ophthalmol. Vis. Sci 58, BIO158–BIO167..

    Not in our library10.1167/iovs.17-21454

  168. 168.

    Pfau M, Lindner M, Gliem M, Steinberg JS, Thiele S, Finger RP, Fleckenstein M, Holz FG, Schmitz-Valckenberg S, 2018a. Mesopic and dark-adapted two-color fundus-controlled perimetry in patients with cuticular, reticular, and soft drusen. Eye 32, 1819–1830..

    Not in our library10.1038/s41433-018-0183-3

  169. 169.

    Pfau M, Lindner M, Steinberg JS, Thiele S, Brinkmann CK, Fleckenstein M, Holz FG, Schmitz-Valckenberg S, 2018b. Visual field indices and patterns of visual field deficits in mesopic and dark-adapted two-colour fundus-controlled perimetry in macular diseases. Br. J. Ophthalmol 102, 1054–1059..

    Not in our library10.1136/bjophthalmol-2017-311012

  170. 170.

    Pfau M, von der Emde L, Dysli C, Möller PT, Thiele S, Lindner M, Schmid M, Rubin DL, Fleckenstein M, Holz FG, Schmitz-Valckenberg S, 2020a. Determinants of cone- and rod-function in geographic atrophy: AI-based structure-function correlation. Am. J. Ophthalmol 217, 162–173..

    Not in our library10.1016/j.ajo.2020.04.003

  171. 171.

    Pfau M, Von Der Emde L, Dysli C, Thiele S, Möller PT, Lindner M, Nadal J, Schmid M, Schmitz-Valckenberg S, Holz FG, Fleckenstein M, 2019. Light sensitivity within areas of geographic atrophy secondary to age-related macular degeneration. Investig. Ophthalmol. Vis. Sci 60, 3992–4001..

    Not in our library10.1167/iovs.19-27178

  172. 172.

    Pfau M, Holz FG, Müller PL, 2020b. Retinal light sensitivity as outcome measure in recessive Stargardt disease. Br. J. Ophthalmol 4 bjophthalmol-2020–316201.

    Not in our library10.1136/bjophthalmol-2020-316201

  173. 173.

    Pfau M, Müller PL, Von Der Emde L, Lindner M, Möller PT, Fleckenstein M, Holz FG, Schmitz-Valckenberg S, 2020c. Mesopic and dark-adapted two-color fundus-controlled perimetry in geographic atrophy secondary to age-related macular degeneration. Retina 40, 169–180..

    Not in our library10.1097/iae.0000000000002337

  174. 174.

    Phthalmology O, 2016. T He B ritish J ournal of. Br. J. Ophthalmol 96, 1404–1409..

    Not in our library10.1136/bjophthalmol

  175. 175.

    Pilotto E, Benetti E, Convento E, Guidolin F, Longhin E, Parrozzani R, Midena E, 2013. Microperimetry, fixndus autofluorescence, and retinal layer changes in progressing geographic atrophy. Can. J. Ophthalmol 48, 386–393..

    Not in our library10.1016/j.jcjo.2013.03.022

  176. 176.

    Plesch A, Klingbeil U, 1989. Optical characteristics of A scanning laser ophthalmoscope. In: Wampler JE (Ed.), New Methods in Microscopy and Low Light Imaging. SPIE, p. 390..

    Not in our library10.1117/12.962721

  177. 177.

    Pondorfer SG, Terheyden JH, Heinemann M, Wintergerst MWM, Holz FG, Finger RP, 2019. Association of vision-related quality of life with visual function in age-related macular degeneration. Sci. Rep 9, 15326.

    Not in our library10.1038/s41598-019-51769-7

  178. 178.

    Prager F, Michels S, Simader C, Geitzenauer W, Schmidt-Erfurth U, Simader C, 2008. Changes in retinal sensitivity in patients with neovascular age-related macular degeneration after systemic bevacizumab (avastin) therapy. Retina 28, 682–688..

    Not in our library10.1097/iae.0b013e318161dc70

  179. 179.

    Querques G, Cascavilla ML, Cavallero E, Triolo G, Querques L, Lattanzio R, Cicinelli MV, Preziosa C, Borrelli E, Bandello F, 2014. Changes in macular function after Ozurdex for retinal vein occlusion. Optom. Vis. Sci 91, 760–768..

    Not in our library10.1097/opx.0000000000000308

  180. 180.

    Ratnarajan G, Jolly JK, Yusuf IH, Salmon JF, 2018. The effect of trabeculectomy surgery on the central visual field in patients with glaucoma using microperimetry and optical coherence tomography. Eye 32, 1365–1371..

    Not in our library10.1038/s41433-018-0095-2

  181. 181.

    Redmond T, Zlatkova MB, Garway-Heath DF, Anderson RS, 2010. The effect of age on the area of complete spatial summation for chromatic and achromatic stimuli. Invest. Ophthalmol. Vis. Sci 51, 6533–6539..

    Not in our library10.1167/iovs.10-5717

  182. 182.

    Reiniger JL, Domdei N, Pfau M, Müller PL, Holz FG, Harmening WM, 2017. Adaptive Optiken – Möglichkeiten für die Diagnostik hereditärer Netzhauterkrankungen. Klin. Monbl. Augenheilkd 234, 311–319..

    Not in our library10.1055/s-0043-100631

  183. 183.

    Remky A, Elsner AE, 2005. Blue on yellow perimetry with scanning laser ophthalmoscopy in patients with age related macular disease. Br. J. Ophthalmol 89, 464–469..

    Not in our library10.1136/bjo.2004.050260

  184. 184.

    Remky A, Elsner AE, Morandi AJ, Beausencourt E, Trempe CL, 2001. Blue-on-yellow perimetry with a scanning laser ophthalmoscope: small alterations in the central macula with aging. J. Opt. Soc. Am. A 18, 1425..

    Not in our library10.1364/josaa.18.001425

  185. 185.

    Robson AG, El-Amir A, Bailey C, Egan CA, Fitzke FW, Webster AR, Bird AC, Holder GE, 2003. Pattern ERG correlates of abnormal fundus autofluorescence in patients with retinitis pigmentosa and normal visual acuity. Investig. Ophthalmol. Vis. Sci 44, 3544–3550..

    Not in our library10.1167/iovs.02-1278

  186. 186.
  187. 187.

    Roh M, Laíns I, Shin HJ, Park DH, Mach S, Vavvas DG, Kim IK, Miller JW, Husain D, Miller JB, 2019. Microperimetry in age-related macular degeneration: association with macular morphology assessed by optical coherence tomography. Br. J. Ophthalmol 103, 1769–1776..

    Not in our library10.1136/bjophthalmol-2018-313316

  188. 188.

    Rohrschneider K, Becker M, Fendrich T, Volcker HE, 1995a. Kinetic fundus perimetry with the scanning laser ophthalmoscope. Klin. Monbl. Augenheilkd 207, 102–110..

    Not in our library10.1055/s-2008-1035356

  189. 189.

    Rohrschneider K, Becker M, Krastel H, Kruse FE, Völcker HE, Fendrich T, 1995b. Static fundus perimetry using the scanning laser ophthalmoscope with an automated threshold strategy. Graefe’s Arch. Clin. Exp. Ophthalmol 233, 743–749..

    Not in our library10.1007/bf00184084

  190. 190.

    Rohrschneider K, Glück R, Becker M, Kruse FE, Burk ROW, Fendrich T, Völcker HE, 1996. Automatic static fundus perimetry for precise detection of early glaucomatous function loss. Investig. Ophthalmol. Vis. Sci 37, 453–462.

    Not in our library

  191. 191.

    Rohrschneider K, Bültmann S, Glück R, Kruse FE, Fendrich T, Völcker HE, 2000. Scanning laser ophthalmoscope fundus perimetry before and after laser photocoagulation for clinically significant diabetic macular edema. Am. J. Ophthalmol 129, 27–32..

    Not in our library10.1016/s0002-9394(99)00270-6

  192. 192.

    Rohrschneider K, Bültmann S, Springer C, 2008. Use of fundus perimetry (microperimetry) to quantify macular sensitivity. Prog. Retin. Eye Res 27, 536–548..

    Not in our library10.1016/j.preteyeres.2008.07.003

  193. 193.

    Roisman L, Ribeiro JC, Fechine FV, Lavinsky D, Moraes N, Campos M, Farah ME, 2014. Does microperimetry have a prognostic value in central serous chorioretinopathy? Retina 34, 713–718..

    Not in our library10.1097/iae.0b013e3182a323fe

  194. 194.

    Roman AJ, Powers CA, Semenov EP, Sheplock R, Aksianiuk V, Russell RC, Sumaroka A, Garafalo AV, Cideciyan AV, Jacobson SG, 2019. Short-wavelength sensitive cone (S-cone) testing as an outcome measure for NR2E3 clinical treatment trials. Int. J. Mol. Sci 20.

    Not in our library10.3390/ijms20102497

  195. 195.

    Rossetti L, Digiuni M, Rosso A, Riva R, Barbaro G, Smolek MK, Orzalesi N, De Cilla S, Autelitano A, Fogagnolo P, 2015. Compass: clinical evaluation of a new instrument for the diagnosis of glaucoma. PloS One 10, e0122157..

    Not in our library10.1371/journal.pone.0122157

  196. 196.

    Sacconi R, Casaluci M, Borrelli E, Mulinacci G, Lamanna F, Gelormini F, Carnevali A, Querques L, Zerbini G, Bandello F, Querques G, 2019. Multimodal imaging assessment of vascular and neurodegenerative retinal alterations in type 1 diabetic patients without fundoscopic signs of diabetic retinopathy. J. Clin. Med 8, 1409..

    Not in our library10.3390/jcm8091409

  197. 197.

    Sachdev A, Edington M, Morjaria R, Chong V, 2019. Comparing microperimetric and structural findings in patients with branch retinal vein occlusion and diabetic macular edema. Retina 39, 446–451..

    Not in our library10.1097/iae.0000000000001961

  198. 198.

    Sallo FB, Peto T, Egan C, Wolf-Schnurrbusch UEK, Clemons TE, Gillies MC, Pauleikhoff D, Rubin GS, Chew EY, Bird AC, Sahel JA, Guymer R, Soubrane G, Gaudric A, Schwartz S, Constable I, Cooney M, Egan C, Singerman L, Gillies MC, Friedlander M, Pauleikhoff D, Moisseiev J, Rosen R, Murphy R, Holz F, Comer G, Blodi B, Do D, Brucker A, Narayanan R, Wolf S, Rosenfeld P, Bernstein PS, Miller JW, 2012. The IS/OS junction layer in the natural history of type 2 idiopathic macular telangiectasia. Investig. Ophthalmol. Vis. Sci 53, 7889–7895..

    Not in our library10.1167/iovs.12-10765

  199. 199.

    Saßmannshausen M, Steinberg JS, Fimmers R, Pfau M, Thiele S, Fleckenstein M, Holz FG, Schmitz-Valckenberg S, 2018. Structure-function analysis in patients with intermediate age-related macular degeneration. Invest. Ophthalmol. Vis. Sci 59, 1599–1608..

    Not in our library10.1167/iovs.17-22712

  200. 200.

    Schiefer U, Pätzold J, Dannheim F, 2005. Konventionelle perimetrie. Teil I: einführung - grundbegriffe. Ophthalmologe 102, 627–646..

    Not in our library10.1007/s00347-005-1189-3

  201. 201.

    Schmidt-Erfurth UM, Michels S, 2003. Changes in confocal indocyanine green angiography through two years after photodynamic therapy with verteporfin. Ophthalmology 110, 1306–1314..

    Not in our library10.1016/s0161-6420(03)00452-4

  202. 202.

    Schmitz-Valckenberg S, Bültmann S, Dreyhaupt J, Bindewald A, Holz FG, Rohrschneider K, 2004. Fundus autofluorescence and fundus perimetry in the junctional zone of geographic atrophy in patients with age-related macular degeneration. Investig. Ophthalmol. Vis. Sci 45, 4470–4476..

    Not in our library10.1167/iovs.03-1311

  203. 203.

    Schmitz-Valckenberg S, Fan K, Nugent A, Rubin GS, Peto T, Tufail A, Egan C, Bird AC, Fitzke FW, 2008. Correlation of functional impairment and morphological alterations in patients with group 2A idiopathic juxtafoveal retinal telangiectasia. Arch. Ophthalmol 126, 330–335..

    Not in our library10.1001/archopht.126.3.330

  204. 204.

    Schmitz-Valckenberg S, Ong EL, Rubin GS, Peto T, Tufail A, Egan CA, Bird AC, Fitzke FW, 2009. Structural and functional changes over time in mactel patients. Retina 29, 1314–1320..

    Not in our library10.1097/iae.0b013e3181a4d2f1

  205. 205.

    Scholl HPN, Bellmann C, Dandekar SS, Bird AC, Fitzke FW, 2004. Photopic and scotopic fine matrix mapping of retinal areas of increased fundus autofluorescence in patients with age-related maculopathy. Investig. Ophthalmol. Vis. Sci 45, 574–583..

    Not in our library10.1167/iovs.03-0495

  206. 206.

    Schönbach EM, Wolfson Y, Strauss RW, Ibrahim MA, Kong X, Muñoz B, Birch DG, Cideciyan AV, Hahn GA, Nittala M, Sunness JS, Sadda SVR, West SK, Scholl HPN, 2017. Macular sensitivity measured with microperimetry in stargardt disease in the progression of atrophy secondary to stargardt disease (ProgStar) study report No. 7. JAMA Ophthalmol 135, 696–703..

    Not in our library10.1001/jamaophthalmol.2017.1162

  207. 207.

    Schönbach Etienne M., Strauss RW, Ibrahim MA, Janes JL, Birch DG, Cideciyan AV, Sunness JS, Muñoz B, Ip MS, Sadda SR, Scholl HPN, 2020a. Faster sensitivity loss around dense scotomas than for overall macular sensitivity in stargardt disease: ProgStar report No. 14. Am. J. Ophthalmol 216, 219–225..

    Not in our library10.1016/j.ajo.2020.03.020

  208. 208.

    Schönbach Etienne M., Strauss RW, Muñoz B, Wolfson Y, Ibrahim MA, Birch DG, Zrenner E, Sunness JS, Ip MS, Sadda SR, West SK, Scholl HPN, 2020. For the ProgStar study group longitudinal microperimetric changes of macular sensitivity in stargardt disease after 12 Months: ProgStar report No. 13. JAMA Ophthalmol 138, 772–779..

    Not in our library10.1001/jamaophthalmol.2020.1735

  209. 209.

    Schönbach Etienne M., Strauss RW, Ahmed MI, Janes JL, Cideciyan AV, Birch DG, Sunness JS, Zrenner E, Ip MS, Kong X, Sadda SR, Scholl HPN, 2020b. The effect of attention on fixation stability during dynamic fixation testing in stargardt disease. Am. J. Ophthalmol 217, 305–316..

    Not in our library10.1016/j.ajo.2020.05.002

  210. 210.

    Simunovic MP, Cullerne A, Colley A, Wilson TD, 2004. How well does color perimetry isolate responses from individual cone mechanisms? J. Glaucoma 13, 22–27..

    Not in our library10.1097/00061198-200402000-00005

  211. 211.

    Simunovic MP, Moore AT, MacLaren RE, 2016. Selective automated perimetry under photopic, mesopic, and scotopic conditions: detection mechanisms and testing strategies. Transl. Vis. Sci. Technol 5, 10..

    Not in our library10.1167/tvst.5.3.10

  212. 212.

    Simunovic MP, Xue K, Jolly JK, MacLaren RE, 2017. Structural and functional recovery following limited iatrogenic macular detachment for retinal gene therapy. JAMA Ophthalmol 135, 234–241..

    Not in our library10.1001/jamaophthalmol.2016.5630

  213. 213.

    Sjöstrand J, Popovic Z, Conradi N, Marshall J, 1999. Morphometric study of the displacement of retinal ganglion cells subserving cones within the human fovea. Graefe’s Arch. Clin. Exp. Ophthalmol. = Albr. von Graefes Arch. fur Klin. und Exp. Ophthalmol 237, 1014–1023..

    Not in our library10.1007/s004170050338

  214. 214.

    Sleiman K, Veerappan M, Winter KP, McCall MN, Yiu G, Farsiu S, Chew EY, Clemons T, Toth CA, Toth CA, Wong W, Huang T, Hubbard GB, Srivastava S, McCall M, Winter K, Sarin N, Hall K, McCollum P, Curtis L, Schuman S, Chiu SJ, Farsiu S, Tai V, Clemons T, Chew E, 2017. Optical coherence tomography predictors of risk for progression to non-neovascular atrophic age-related macular degeneration. Ophthalmology 124, 1764–1777..

    Not in our library10.1016/j.ophtha.2017.06.032

  215. 215.

    Sloan LL, 1940. Instruments and technics for the clinical testing of light sense. Arch. Ophthalmol 24, 258..

    Not in our library10.1001/archopht.1940.00870020050006

  216. 216.

    Spahr J, Fankhauser F, 1974. On automation of perimetry. Problems and solutions. Annee Ther. Clin. Ophtalmol 25, 337–346.

    Not in our library

  217. 217.

    Springer C, Bültmann S, Völcker HE, Rohrschneider K, 2005. Fundus perimetry with the Micro Perimeter 1 in normal individuals: comparison with conventional threshold perimetry. Ophthalmology 112, 848–854..

    Not in our library10.1016/j.ophtha.2004.11.051

  218. 218.

    Springer C, Völcker HE, Rohrschneider K, 2006. Chorioretinopathia centralis serosa - netzhautfunktion und -morphologie: mikroperimetrie und optische kohärenztomografie im vergleich. Ophthalmologe 103, 791–797..

    Not in our library10.1007/s00347-006-1396-6

  219. 219.

    Squirrell DM, Mawer NP, Mody CH, Brand CS, 2010. Visual outcome after intravitreal ranibizumab for wet age-related macular degeneration: a comparison between best-corrected visual acuity and Microperimetry. Retina 30, 436–442..

    Not in our library10.1097/iae.0b013e3181bd2f29

  220. 220.

    Steinberg JS, Fitzke FW, Fimmers R, Fleckenstein M, Holz FG, Schmitz-Valckenberg S, 2015. Scotopic and photopic microperimetry in patients with reticular drusen and age-related macular degeneration. JAMA Ophthalmol 133, 690–697..

    Not in our library10.1001/jamaophthalmol.2015.0477

  221. 221.

    Steinberg JS, Saßmannshausen M, Fleckenstein M, Fimmers R, Oishi A, Holz FG, Schmitz-Valckenberg S, 2016. Correlation of partial outer retinal thickness with scotopic and mesopic fundus-controlled perimetry in patients with reticular drusen. Am. J. Ophthalmol 168, 52–61..

    Not in our library10.1016/j.ajo.2016.04.025

  222. 222.

    Steinberg JS, Saßmannshausen M, Pfau M, Fleckenstein M, Finger RP, Holz FG, Schmitz-Valckenberg S, 2017. Evaluation of two systems for fundus-controlled scotopic and mesopic perimetry in eye with age-related macular degeneration. Transl. Vis. Sci. Technol 6, 7..

    Not in our library10.1167/tvst.6.4.7

  223. 223.

    Steinman RM, 1965. Effect of target size, luminance, and color on monocular fixation*. J. Opt. Soc. Am 55, 1158..

    Not in our library10.1364/josa.55.001158

  224. 224.

    Stockman A, Sharpe LT, 2000. The spectral sensitivities of the middle- and long-wavelength-sensitive cones derived from measurements in observers of known genotype. Vis. Res 40, 1711–1737..

    Not in our library10.1016/s0042-6989(00)00021-3

  225. 225.

    Stürmer J, Schrödel C, Rappl W, 1991. Scanning Laser Ophthalmoscope for Static Fundus Perimetry in Glaucomatous Nerve-Fiber Bundle Defects. In: Millam RP, Heijl A (Eds.), Perimetry Update 1990/91. Kugler & Ghedini Publications, pp. 85–92.

    Not in our library

  226. 226.

    Sulzbacher F, Kiss C, Kaider A, Eisenkoelbl S, Munk M, Roberts P, Sacu S, Schmidt-Erfurth U, 2012. Correlation of SD-OCT features and retinal sensitivity in neovascular age-related macular degeneration. Investig. Ophthalmol. Vis. Sci 53, 6448–6455..

    Not in our library10.1167/iovs.11-9162

  227. 227.

    Sumaroka A, Garafalo AV, Semenov EP, Sheplock R, Krishnan AK, Roman AJ, Jacobson SG, Cideciyan AV, 2019. Treatment potential for macular cone vision in leber congenital amaurosis due to CEP290 or NPHP5 mutations: predictions from artificial intelligence. Investig. Ophthalmol. Vis. Sci 60, 2551–2562..

    Not in our library10.1167/iovs.19-27156

  228. 228.

    Sunness JS, 2008. What you see is not always what you get in atrophic macular disease. Retin. Cases Brief Rep 2, 205–208..

    Not in our library10.1097/icb.0b013e31806011e6

  229. 229.

    Sunness JS, Johnson MA, Massof RW, Kays DL, 1987. Wilmer fundus camera stimulator. Appl. Optic 26, 1487..

    Not in our library10.1364/ao.26.001487

  230. 230.

    Sunness JS, Johnson MA, Massof RW, Marcus S, 1988. Retinal sensitivity over drusen and nondrusen areas: a study using fundus perimetry. Arch. Ophthalmol 106, 1081–1084..

    Not in our library10.1001/archopht.1988.01060140237032

  231. 231.

    Sunness JS, Schuchard RA, Shen N, Rubin GS, Dagnelie G, Haselwood DM, 1995. Landmark-driven fundus perimetry using the scanning laser ophthalmoscope. Investig. Ophthalmol. Vis. Sci 36, 1863–1874.

    Not in our library

  232. 232.

    Sunness JS, Applegate CA, Haselwood D, Rubin GS, 1996. Fixation patterns and reading rates in eyes with central scotomas from advanced atrophic age-related macular degeneration and Stargardt disease. Ophthalmology 103, 1458–1466..

    Not in our library10.1016/s0161-6420(96)30483-1

  233. 233.

    Sunness JS, Rubin GS, Zuckerbrod A, Applegate CA, 2008. Foveal-sparing scotomas in advanced dry age-related macular degeneration. J. Vis. Impair. Blind. (JVIB) 102, 600–610..

    Not in our library10.1177/0145482x0810201004

  234. 234.

    Szepessy Z, Barboni MTS, Farkas A, Nagy ZZ, Németh J, 2019. Retinal function in patients with adalimumab treatment: long-term follow-up with microperimetry. Ocul. Immunol. Inflamm 1–6..

    Not in our library10.1080/09273948.2019.1672198

  235. 235.

    Tagami Y, Isayama Y, 1977. Quantitative Maculometry Using a New Instrument in Cases of Optic Neuropathies. In: Japanese Journal of Clinical Ophthalmology, pp. 639–643.

    Not in our library

  236. 236.

    Takahashi A, Ooto S, Yamashiro K, Oishi A, Tamura H, Nakanishi H, Ueda-Arakawa N, Tsujikawa A, Yoshimura N, 2016. Photoreceptor damage and reduction of retinal sensitivity surrounding geographic atrophy in age-related macular degeneration. Am. J. Ophthalmol 168, 260–268..

    Not in our library10.1016/j.ajo.2016.06.006

  237. 237.

    Testa F, Melillo P, Di Iorio V, Orrico A, Attanasio M, Rossi S, Simonelli F, 2014. Macular function and morphologic features in juvenile stargardt disease: longitudinal study. Ophthalmology 121, 2399–2405..

    Not in our library10.1016/j.ophtha.2014.06.032

  238. 238.

    Thompson DA, Iannaccone A, Ali RR, Arshavsky VY, Audo I, Bainbridge JWB, Besirli CG, Birch DG, Branham KE, Cideciyan AV, Daiger SP, Dalkara D, Duncan JL, Fahim AT, Flannery JG, Gattegna R, Heckenlively JR, Heon E, Jayasundera KT, Khan NW, Klassen H, Leroy BP, Molday RS, Musch DC, Pennesi ME, Petersen-Jones SM, Pierce EA, Rao RC, Reh TA, Sahel JA, Sharon D, Sieving PA, Strettoi E, Yang P, Zacks DN, Consortium TM, 2020. Advancing clinical trials for inherited retinal diseases: recommendations from the second monaciano symposium. Transl. Vis. Sci. Technol 9, 2..

    Not in our library10.1167/tvst.9.7.2

  239. 239.

    Timberlake GT, Mainster MA, Webb RH, Hughes GW, Trempe CL, 1982. Retinal localization of scotomata by scanning laser ophthalmoscopy. Investig. Ophthalmol. Vis. Sci 22, 91–97.

    Not in our library

  240. 240.

    Timberlake GT, Peli E, Essock EA, Augliere RA, 1987. Reading with a macular scotoma. II. Retinal locus for scanning text. Investig. Ophthalmol. Vis. Sci 28, 1268–1274.

    Not in our library

  241. 241.

    Tita-Nistor L, González EG, Mkowitz SN, Steinbach MJ, 2009. Plasticity of fixation in patients with central vision loss. Vis. Neurosci 26, 487–494..

    Not in our library10.1017/s0952523809990265

  242. 242.

    Trantas NG, 1955. Applications et résultats d’un moyen simple d’examen de la photosensibilité de la rétine. Bull. Soc. Ophtalmol. Fr 55, 499–513.

    Not in our library

  243. 243.

    Tsai ASH, Gan ATL, Ting DSW, Wong CW, Teo KYC, Tan ACS, Lee SY, Wong TY, Tan GSW, Gemmy Cheung CM, 2019. Diabetic macular ischemia. Retina 1..

    Not in our library10.1097/iae.0000000000002721

  244. 244.

    Turpin A, McKendrick AM, Johnson CA, Vingrys AJ, 2003. Properties of perimetric threshold estimates from full threshold, ZEST, and SITA-like strategies, as determined by computer simulation. Investig. Ophthalmol. Vis. Sci 44, 4787–4795..

    Not in our library10.1167/iovs.03-0023

  245. 245.

    Turpin A, Chen S, Sepulveda JA, McKendrick AM, 2015. Customizing structure–function displacements in the macula for individual differences. Invest. Ophthalmol. Vis. Sci 56, 5984–5989..

    Not in our library10.1167/iovs.15-17384

  246. 246.

    Tzaridis S, Herrmann P, Issa PC, Esposti SD, Wagner SK, Fruttiger M, Egan C, Rubin G, Holz FG, Heeren TFC, 2019. Binocular inhibition of reading in macular telangiectasia type 2. Investig. Ophthalmol. Vis. Sci 60, 3835–3841..

    Not in our library10.1167/iovs.18-26414

  247. 247.

    van Dijk EHC, Fauser S, Breukink MB, Blanco-Garavito R, Groenewoud JMM, Keunen JEE, Peters PJH, Dijkman G, Souied EH, MacLaren RE, Querques G, Downes SM, Hoyng CB, Boon CJF, 2018. Half-Dose photodynamic therapy versus high-density subthreshold micropulse laser treatment in patients with chronic central serous chorioretinopathy: the PLACE trial. Ophthalmology 125, 1547–1555..

    Not in our library10.1016/j.ophtha.2018.04.021

  248. 248.

    Vianna JR, Chauhan BC, 2015. How to detect progression in glaucoma. Prog. Brain Res 221, 135–158..

    Not in our library10.1016/bs.pbr.2015.04.011

  249. 249.

    Vingolo EM, Cavarretta S, Domanico D, Parisi F, Malagola R, 2007. Microperimetric biofeedback in AMD patients. Appl. Psychophysiol. Biofeedback 32, 185–189..

    Not in our library10.1007/s10484-007-9038-6

  250. 250.

    Vingolo EM, Salvatore S, Cavarretta S, 2009. Low-vision rehabilitation by means of MP-1 biofeedback examination in patients with different macular diseases: a pilot study. Appl. Psychophysiol. Biofeedback 34, 127–133..

    Not in our library10.1007/s10484-009-9083-4

  251. 251.

    Vingolo EM, Salvatore S, Limoli PG, 2013. MP-1 biofeedback: luminous pattern stimulus versus acoustic biofeedback in age related macular degeneration (AMD). Appl. Psychophysiol. Biofeedback 38, 11–16..

    Not in our library10.1007/s10484-012-9203-4

  252. 252.

    von der Emde L, Pfau M, Dysli C, Thiele S, Moller PT, Lindner M, Schmid M, Fleckenstein M, Holz FG, Schmitz-Valckenberg S, 2019a. Artificial intelligence for morphology-based function prediction in neovascular age-related macular degeneration. Sci. Rep 9, 11132.

    Not in our library10.1038/s41598-019-47565-y

  253. 253.

    von der Emde L, Pfau M, Thiele S, Möller PT, Hassenrik R, Fleckenstein M, Holz FG, Schmitz-Valckenberg S, 2019b. Mesopic and dark-adapted two-color fundus-controlled perimetry in choroidal neovascularization secondary to age-related macular degeneration. Transl. Vis. Sci. Technol 8, 7..

    Not in our library10.1167/tvst.8.1.7

  254. 254.

    von Noorden GK, Mackensen G, 1962. Phenomenology of eccentric fixation. Am. J. Ophthalmol 53, 642–661..

    Not in our library10.1016/0002-9394(62)91987-6

  255. 255.

    Vujosevic S, Midena E, Pilotto E, Radin PP, Chiesa L, Cavarzeran F, 2006. Diabetic macular edema: correlation between microperimetry and optical coherence tomography findings. Investig. Ophthalmol. Vis. Sci 47, 3044–3051..

    Not in our library10.1167/iovs.05-1141

  256. 256.

    Vujosevic S, Pilotto E, Bottega E, Benetti E, Cavarzeran F, Midena E, 2008. Retinal fixation impairment in diabetic macular edema. Retina 28, 1443–1450..

    Not in our library10.1097/iae.0b013e318183571e

  257. 257.

    Vujosevic S, Casciano M, Pilotto E, Boccassini B, Varano M, Midena E, 2011. Diabetic macular edema: fundus autofluorescence and functional correlations. Investig. Ophthalmol. Vis. Sci 52, 442–448..

    Not in our library10.1167/iovs.10-5588

  258. 258.

    Vujosevic S, Berton M, Bini S, Casciano M, Cavarzeran F, Midena E, 2016. Hyperreflective retinal spots and visual function after anti-vascular endothelial growth factor treatment in center-involving diabetic macular edema. Retina 36, 1298–1308..

    Not in our library10.1097/iae.0000000000000912

  259. 259.

    Vujosevic S, Pucci P, Casciano M, Longhin E, Convento E, Bini S, Midena E, 2017a. Long-term longitudinal modifications in mesopic microperimetry in early and intermediate age-related macular degeneration. Graefe’s Arch. Clin. Exp. Ophthalmol 255, 301–309..

    Not in our library10.1007/s00417-016-3466-z

  260. 260.

    Vujosevic S, Torresin T, Berton M, Bini S, Convento E, Midena E, 2017b. Diabetic macular edema with and without subfoveal neuroretinal detachment: two different morphologic and functional entities. Am. J. Ophthalmol 181, 149–155..

    Not in our library10.1016/j.ajo.2017.06.026

  261. 261.

    Vujosevic S, Heeren TFC, Florea D, Leung I, Pauleikhoff D, Sallo F, Bird A, Peto T, 2018. Scotoma characteristics IN macular telangiectasia type 2: MacTel project report No. 7-The MacTel research group. Retina 38 Suppl 1, S14–S19..

    Not in our library10.1097/iae.0000000000001693

  262. 262.

    Wakabayashi T, Sawa M, Gomi F, Tsujikawa M, 2010. Correlation of fundus autofluorescence with photoreceptor morphology and functional changes in eyes with retinitis pigmentosa. Acta Ophthalmol 88, e177–e183..

    Not in our library10.1111/j.1755-3768.2010.01926.x

  263. 263.

    Wald G, 1945. Human vision and the spectrum. Science 84 101, 653–658..

    Not in our library10.1126/science.101.2635.653

  264. 264.

    Wall M, Woodward KR, Doyle CK, Zamba G, 2010. The effective dynamic ranges of standard automated perimetry sizes III and V and motion and matrix perimetry. Arch. Ophthalmol 128, 570–576..

    Not in our library10.1001/archophthalmol.2010.71

  265. 265.

    Watson AB, 2014. A formula for human retinal ganglion cell receptive field density as a function of visual field location. J. Vis 14.

    Not in our library10.1167/14.7.15

  266. 266.

    Watzke RC, Allen L, 1969. Subjective slitbeam sign for macular disease. Am. J. Ophthalmol 68, 449–453..

    Not in our library10.1016/0002-9394(69)90712-0

  267. 267.

    Webb RH, Hughes GW, 1981. Scanning laser ophthalmoscope. IEEE Trans. Biomed. Eng. BME- 28, 488–492..

    Not in our library10.1109/tbme.1981.324734

  268. 268.

    Weingessel B, Sacu S, Vécsei-Marlovits PV, Weingessel A, Richter-Mueksch S, Schmidt-Erfurth U, 2009. Interexaminer and intraexaminer reliability of the microperimeter MP-1. Eye 23, 1052–1058..

    Not in our library10.1038/eye.2008.237

  269. 269.

    Weinreb RN, Kaufman PL, 2009. The glaucoma research community and FDA look to the future: a report from the NEI/FDA CDER glaucoma clinical trial design and endpoints symposium. Investig. Ophthalmol. Vis. Sci 50, 1497–1505..

    Not in our library10.1167/iovs.08-2843

  270. 270.

    Weinreb RN, Aung T, Medeiros FA, 2014. The pathophysiology and treatment of glaucoma: a review. JAMA, J. Am. Med. Assoc 311, 1901–1911..

    Not in our library10.1001/jama.2014.3192

  271. 271.

    Weleber RG, Smith TB, Peters D, Chegarnov EN, Gillespie SP, Francis PJ, Gardiner SK, Paetzold J, Dietzsch J, Schiefer U, Johnson CA, 2015. VFMA: topographic analysis of sensitivity data from full-field static perimetry. Transl. Vis. Sci. Technol 4, 14..

    Not in our library10.1167/tvst.4.2.14

  272. 272.

    Welker SG, Pfau M, Heinemann M, Schmitz-Valckenberg S, Holz FG, Finger RP, 2018. Retest reliability of mesopic and dark-adapted microperimetry in patients with intermediate age-related macular degeneration and age-matched controls. Investig. Ophthalmol. Vis. Sci 59, AMD152–AMD159..

    Not in our library10.1167/iovs.18-23878

  273. 273.

    Wildberger H, Robert Y, 1988. Visual fatigue during prolonged visual Field testing in optic neuropathies. Neuro Ophthalmol 8, 167–174..

    Not in our library10.3109/01658108808996037

  274. 274.

    Wilson IR, Jolly J, Downes S, MacLaren RE, 2018. Beyond the average threshold: alternatives in the analysis of microperimetry data. Invest. Ophthalmol. Vis. Sci 59, 1698.

    Not in our library

  275. 275.

    Wong EN, Mackey DA, Morgan WH, Chen FK, 2016. Inter-device comparison of retinal sensitivity measurements: the CenterVue MAIA and the Nidek MP-1. Clin. Exp. Ophthalmol 44, 15–23..

    Not in our library10.1111/ceo.12629

  276. 276.

    Wong EN, De Soyza JDA, Mackey DA, Constable IJ, Chen FK, 2017. Intersession test-retest variability of microperimetry in type 2 macular telangiectasia. Transl. Vis. Sci. Technol 6, 7..

    Not in our library10.1167/tvst.6.6.7

  277. 277.

    Wu Z, Medeiros FA, 2018a. Comparison of visual field point-wise event-based and global trend-based analysis for detecting glaucomatous progression. Transl. Vis. Sci. Technol 7, 20..

    Not in our library10.1167/tvst.7.4.20

  278. 278.

    Wu Z, Medeiros FA, 2018b. Impact of different visual field testing paradigms on sample size requirements for glaucoma clinical trials. Sci. Rep 8, 4889..

    Not in our library10.1038/s41598-018-23220-w

  279. 279.

    Wu Z, Medeiros FA, 2019. Sample size requirements of glaucoma clinical trials when using combined optical coherence tomography and visual field endpoints. Sci. Rep 9, 18886.

    Not in our library10.1038/s41598-019-55345-x

  280. 280.

    Wu Z, Ayton LN, Guymer RH, Luu CD, 2013. Intrasession test-retest variability of microperimetry in age-related macular degeneration. Investig. Ophthalmol. Vis. Sci 54, 7378–7385..

    Not in our library10.1167/iovs.13-12617

  281. 281.

    Wu Z, Ayton LN, Luu CD, Guymer RH, 2014. Relationship between retinal microstructures on optical coherence tomography and microperimetry in age-related macular degeneration. Ophthalmology 121, 1445–1452..

    Not in our library10.1016/j.ophtha.2014.01.025

  282. 282.

    Wu Z, Ayton LN, Makeyeva G, Guymer RH, Luu CD, 2015a. Impact of reticular pseudodrusen on microperimetry and multifocal electroretinography in intermediate age-related macular degeneration. Invest. Ophthalmol. Vis. Sci 56, 2100–2106..

    Not in our library10.1167/iovs.14-16210

  283. 283.

    Wu Z, Jung CJ, Ayton LN, Luu CD, Guymer RH, 2015b. Test—retest repeatability of microperimetry at the border of deep scotomas. Investig. Ophthalmol. Vis. Sci 56, 2606–2611..

    Not in our library10.1167/iovs.14-15977

  284. 284.

    Wu Z, Cunefare D, Chiu E, Luu CD, Ayton LN, Toth CA, Farsiu S, Guymer RH, 2016a. Longitudinal associations between microstructural changes and microperimetry in the early stages of age-related macular degeneration. Investig. Ophthalmol. Vis. Sci 57, 3714–3722..

    Not in our library10.1167/iovs.15-18294

  285. 285.

    Wu Z, McKendrick AM, Hadoux X, Fan Gaskin JC, Ang GS, Sarossy MG, Crowston JG, 2016b. Test-retest variability of fundus-tracked perimetry at the peripapillary region in open angle glaucoma. Investig. Ophthalmol. Vis. Sci 57, 3619–3625..

    Not in our library10.1167/iovs.15-19002

  286. 286.

    Wu Z, Cimetta R, Caruso E, Guymer RH, 2019a. Performance of a defect-mapping microperimetry approach for characterizing progressive changes in deep scotomas. Transl. Vis. Sci. Technol 8, 16..

    Not in our library10.1167/tvst.8.4.16

  287. 287.

    Wu Z, Crabb DP, Chauhan BC, Crowston JG, Medeiros FA, 2019b. Improving the feasibility of glaucoma clinical trials using trend-based visual field progression end points. Ophthalmol. Glaucoma 2, 72–77..

    Not in our library10.1016/j.ogla.2019.01.004

  288. 288.

    Wu Z, Luu CD, Hodgson LAB, Caruso E, Brassington KH, Tindill N, Aung KZ, Harper CA, Wickremasinghe SS, Sandhu SS, McGuinness MB, Chen FK, Chakravarthy U, Arnold JJ, Heriot WJ, Durkin SR, Wintergerst MWM, Gorgi Zadeh S, Schultz T, Finger RP, Cohn AC, Baglin EK, Sharangan P, Guymer RH, 2019c. Secondary and exploratory outcomes of the subthreshold nanosecond laser intervention randomized trial in age-related macular degeneration: a lead study report. Ophthalmol. Retin 3, 1026–1034..

    Not in our library10.1016/j.oret.2019.07.008

  289. 289.

    Wyatt HJ, Dul MW, Swanson WH, 2007. Variability of visual field measurements is correlated with the gradient of visual sensitivity. Vis. Res 47, 925–936..

    Not in our library10.1016/j.visres.2006.12.012

  290. 290.

    Xue K, Jolly JK, Barnard AR, Rudenko A, Salvetti AP, Patrício MI, Edwards TL, Groppe M, Orlans HO, Tolmachova T, Black GC, Webster AR, Lotery AJ, Holder GE, Downes SM, Seabra MC, MacLaren RE, 2018. Beneficial effects on vision in patients undergoing retinal gene therapy for choroideremia. Nat. Med 24, 1507–1512..

    Not in our library10.1038/s41591-018-0185-5

  291. 291.

    Yohannan J, Bittencourt M, Sepah YJ, Hatef E, Sophie R, Moradi A, Liu H, Ibrahim M, Do DV, Coulantuoni E, Nguyen QD, 2013. Association of retinal sensitivity to integrity of photoreceptor inner/outer segment junction in patients with diabetic macular edema. Ophthalmology 120, 1254–1261..

    Not in our library10.1016/j.ophtha.2012.12.003

  292. 292.

    Yohannan J, Wang J, Brown J, Chauhan BC, Boland MV, Friedman DS, Ramulu PY, 2017. Evidence-based criteria for assessment of visual field reliability. Ophthalmology 124, 1612–1620..

    Not in our library10.1016/j.ophtha.2017.04.035

  293. 293.

    Yousefi S, Kiwaki T, Zheng Y, Sugiura H, Asaoka R, Murata H, Lemij H, Yamanishi K, 2018. Detection of longitudinal visual field progression in glaucoma using machine learning. Am. J. Ophthalmol 193, 71–79..

    Not in our library10.1016/j.ajo.2018.06.007

  294. 294.

    Youssef MM, El-Fayoumi D, Sidky MK, Hegazy AI, Marzouk H, Eltanamly RM, 2017. Value of microperimetry in detecting early retinal toxicity of hydroxychloroquine in children with juvenile systemic lupus erythematosus. Ophthalmol. J. Int. d’ophtalmologie. Int. J. Ophthalmol. Zeitschrift fur Augenheilkd 237, 180–184..

    Not in our library10.1159/000461595

  295. 295.

    Yusuf IH, Jolly JK, Ratnarajan G, Salmon JF, 2018. Microperimetry and optical coherence tomography imaging in the fellow eye of patients with unilateral focal ischaemic glaucoma. Eye 32, 1372–1379..

    Not in our library10.1038/s41433-018-0094-3

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.